Explore

$13 train fare spikes to $150 for World Cup fans attending matches in New Jersey

$13 train fare spikes to $150 for World Cup fans attending matches in New Jersey

Sky-high ticket prices won’t be the only thing emptying the wallets of soccer fans attending World Cup matches at some U.S. venues this spring

Cochrane Review Questions Efficacy of Anti-Amyloid Alzheimer's Drugs

Cochrane Review Questions Efficacy of Anti-Amyloid Alzheimer's Drugs

A recent analysis by the Cochrane health research organization has cast doubt on the efficacy of anti-amyloid drugs used in treating Alzheimer's disease. The review assessed 17 studies involving over 20,000 participants and concluded that these drugs, including Biogen and Eisai's Leqembi and Eli Lilly's Kisunla, likely have no clinically meaningful positive effects on cognitive function or dementia severity. The analysis also noted a small increase in the risk of brain swelling associated with these medications. Despite some drugs like Leqembi and Kisunla receiving FDA approval based on statistically significant reductions in clinical decline, the review suggests that the overall impact of amyloid-targeting therapies is minimal.

How 50 days of the Iran war led to the loss of $50 billion worth of oil

How 50 days of the Iran war led to the loss of $50 billion worth of oil

By Stephanie Kelly and Ahmad Ghaddar LONDON, April 17 (Reuters) - The world has lost over $50 billion worth of crude oil that has not been produced since the Iran war began nearly 50 days ago and the aftershock of the crisis will be felt for months and even years to come, according to analysts and

Live Nation Verdict Fuels Private Antitrust Suits Over Ticket Sales

Live Nation Verdict Fuels Private Antitrust Suits Over Ticket Sales

Live Nation Verdict Fuels Private Antitrust Suits Over Ticket Sales

Oil prices drop 13% and the Dow soars over 1,000 points after Iran reopens the Strait of Hormuz

Oil prices drop 13% and the Dow soars over 1,000 points after Iran reopens the Strait of Hormuz

Oil prices fell by 13%, and the Dow Jones Industrial Average soared more than 1,000 points after Iran said the Strait of Hormuz is fully open

CMS Hemp CBD Program Lawsuit Highlights Regulatory Disparities in Cannabinoid Medicine

CMS Hemp CBD Program Lawsuit Highlights Regulatory Disparities in Cannabinoid Medicine

A lawsuit challenging the Centers for Medicare & Medicaid Services (CMS) hemp access initiative is raising significant legal questions about the federal healthcare infrastructure. The lawsuit, brought by MMJ International Holdings, argues that CMS has created a federal cannabinoid access pathway within Medicare without requiring FDA drug approval. This contrasts with the stringent requirements imposed on pharmaceutical developers like MMJ, who must undergo extensive clinical trials and regulatory approvals. The case highlights a regulatory asymmetry that could impact the future of cannabinoid medicine in the U.S.

Jury finds that Ticketmaster and Live Nation had an anticompetitive monopoly over big concert venues

Jury finds that Ticketmaster and Live Nation had an anticompetitive monopoly over big concert venues

A jury has found that concert giant Live Nation and its Ticketmaster subsidiary engaged in an anticompetitive monopoly

Mamdani, Hochul propose tax on New York second homes worth more than $5 billion

Mamdani, Hochul propose tax on New York second homes worth more than $5 billion

By Maria Tsvetkova NEW YORK, April 15 (Reuters) - New York State Governor Kathy Hochul proposed on Wednesday a new tax on second homes worth over $5 million that was backed by New York Mayor Zohran Mamdani.

CMS Hemp CBD Program Lawsuit Highlights Legal Risks Over FDA Approval

CMS Hemp CBD Program Lawsuit Highlights Legal Risks Over FDA Approval

A lawsuit against the Centers for Medicare & Medicaid Services (CMS) challenges the agency's hemp access initiative, which allows cannabinoids into Medicare infrastructure without FDA approval. MMJ International Holdings and other plaintiffs argue that this creates an unfair advantage for CMS, as pharmaceutical developers must adhere to stringent FDA standards. The case questions whether CMS can introduce therapeutic cannabinoids without the same regulatory scrutiny required for other drugs. The lawsuit emphasizes the procedural fairness of integrating cannabinoids into federal healthcare without FDA validation, contrasting with the rigorous approval process faced by botanical drug developers.

AI ruling prompts warnings from US lawyers: Your chats could be used against you

AI ruling prompts warnings from US lawyers: Your chats could be used against you

By Mike Scarcella April 15 (Reuters) - As people increasingly turn to artificial intelligence for advice, some U.S. lawyers are telling their clients not to treat AI chatbots like trusted confidants when their freedom or legal liability is on the line.

Exclusive-European buyers hold talks to ship Canadian LNG via Panama Canal to diversify supply

Exclusive-European buyers hold talks to ship Canadian LNG via Panama Canal to diversify supply

By Amanda Stephenson CALGARY, April 15 (Reuters) - European buyers, including Germany's Uniper, are exploring the possibility of purchasing liquefied natural gas from Canada's Pacific coast and shipping it through the Panama Canal as part of a long-term strategy to diversify supply, an effort made

Trump posts image of himself with Jesus as administration's pope criticism continues

Trump posts image of himself with Jesus as administration's pope criticism continues

By Helen Coster NEW YORK, April 15 (Reuters) - U.S. President Donald Trump posted an apparently AI-generated image of Jesus embracing him on Wednesday, two days after he deleted a post that prompted criticism that the Republican president had compared himself to Jesus.